Anti-KLK5/Kallikrein 5 Antibody represents a highly specialized monoclonal or bispecific antibody specifically engineered to target the human kallikrein-related peptidase 5 with exceptional binding affinity and selectivity, effectively facilitating the measurable inhibition of excessive epidermal proteolytic activity across various preclinical experimental models to evaluate the restoration of the skin barrier function and the suppression of pro-inflammatory signaling pathways during strictly monitored laboratory observation periods to ensure high experimental sensitivity and accuracy in specialized research environments.